Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Advanced Malignancies × cemiplimab × Clear all

Phase

Status

Withdrawn 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Prostatic Neoplasms 1 Oropharyngeal Neoplasms 1 Mycosis Fungoides 1 Lung Neoplasms 1 Hodgkin Disease 1 Head and Neck Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Brain Neoplasms 1 Advanced Malignancies 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02520245 2016-11-07

Companion Study for Patients Who Completed Participation in a REGN2810 (Anti-PD-1) Clinical Study

Regeneron Pharmaceuticals

Phase 1 Withdrawn

Advanced Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡